Recurrent Non-small Cell Lung Cancer Terminated Phase 1 Trials for Sargramostim (DB00020)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00088933Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTreatment